Skip to content

Mindfulness-Based Stress Reduction for Solid Organ Transplant Recipients: A Randomized Controlled Trial

C. Gross, M. Kreitzer, William Thomas, Maryanne Reilly-Spong, Michel A. Cramer Bornemann, J. Nyman, Patricia A Frazier, H. Ibrahim

Alternative Therapies in Health and Medicine September 1, 2010

Study at a glance

AI-extracted from the abstract
Characteristics Controlled trial with 2-staged randomization Randomized Peer reviewed
Sample size 138
Population Recipients of kidney, kidney/pancreas, liver, heart, or lung transplants
Interventions Mindfulness-Based Stress Reduction (MBSR) Health Education
Duration 8-week intervention, 1-year follow-up
Measures STAI, CES-D, PSQI
Topics Meditation
Key findings MBSR reduced anxiety and sleep symptoms with medium treatment effects (0.51 and 0.56) at 1 year compared to Health Education. Within the MBSR group, anxiety, depression, and sleep symptoms decreased and quality of life improved by 8 weeks, with benefits retained at 1 year; Health Education improvements were smaller and not sustained.

Abstract

Context Patients who have received solid organ transplants continue to experience a myriad of complex symptoms related to their underlying disease and to chronic immunosuppression that reduce the quality of life. Beneficial non-pharmacologic therapies to address these symptoms have not been established in the transplant population.

Objective: Assess the efficacy of Mindfulness-Based Stress Reduction (MBSR) in reducing symptoms of anxiety, depression, and poor sleep in transplant patients. Design, Setting and Patients Controlled trial with a 2-staged randomization. Recipients of kidney, kidney/pancreas, liver, heart or lung transplants were randomized to MBSR (n=72) or Health Education (n=66) initially or after serving on a waitlist. Mean age was 54 (range 21–75 years); 55% were men and 91% were white.

Interventions: MBSR, a mindfulness meditation training program consisting of 8 weekly 2.5 hour classes; Health Education, a peer-led active control. Primary Outcome Measures Anxiety (STAI), depression (CES-D), and sleep quality (PSQI) scales assessed by self-report at baseline, 8 weeks, 6 months and 1 year.

Results: Benefits of MBSR were above and beyond those afforded by the active control. MBSR reduced anxiety and sleep symptoms (Ps<0.02), with medium treatment effects (0.51 and 0.56) at 1 year compared to Health Education in intention-to-treat analyses. Within the MBSR group anxiety, depression and sleep symptoms decreased and quality of life measures improved by 8 weeks (Ps <0.01, all), and benefits were retained at 1 year (Ps<0.05, all). Initial symptom reductions in the Health Education group were smaller and not sustained. Comparisons to the waitlist confirmed the impact of MBSR on both symptoms and quality of life, whereas Health Education improvements were limited to quality of life ratings.

Conclusions: MBSR reduced distressing symptoms of anxiety, depression and poor sleep and improved quality of life. Benefits were sustained over 1 year. A health education program provided fewer benefits, and effects were not as durable. MBSR is a relatively inexpensive, safe and effective community-based intervention.